University of Vermont

College of Medicine

Department of Pathology and Laboratory Medicine

Bio for Kelly Butnor, M.D.
Kelly Butnor, M.D.

Kelly Butnor, M.D.

Professor, Department of Pathology & Laboratory Medicine


Contact Information
E-mail: Kelly.Butnor@uvmhealth.org
Office Location:
EP2-120

Expertise

Lung and thoracic pathology

Postdoctoral Training

2001 - 2002 Chief Resident in Pathology, Duke University Medical Center, Durham, NC
2000 - 2001 Fellow, Pulmonary Pathology, Duke University Medical Center, Durham, NC
1998 - 2002 Resident, Anatomic and Clinical Pathology, Duke University Medical Center, Durham, NC

Education

1993 B.S., Biology, summa cum laude with Honors, Syracuse University, Syracuse, New York
1997 M.D., Duke University School of Medicine, Durham, North Carolina

Academic Appointments

2015-Present Professor, Department of Pathology & Laboratory Medicine, University of Vermont
2008 - 2015 Associate Professor, University of Vermont, Department of Pathology, Burlington, Vermont
2002 - 2008 Assistant Professor. University of Vermont, Department of Pathology, Burlington, Vermont

Awards and Honors

2001 - 2002 Chief Resident in Pathology, Duke University Medical Center
2002 North Carolina Society of Pathologists Resident Research Award
2002 Society for Ultrastructural Pathology Meritorious Achievement Award
1993 Syracuse University Honors Program Outstanding Undergraduate Thesis Award
1993 Phi Beta Kappa

Publications

Sauter JL, Butnor KJ. Clinical and cost implications of universal versus locally advanced and advanced-stage-only molecular testing for epidermal growth factor receptor (EGFR) mutations and anaplastic lymphoma kinase (ALK) rearrangements in non-small cell lung carcinoma: a tertiary academic institution experience. Arch Pathol Lab Med 2015 (in press)

Cunniff B, Newick K, Nelson KJ, Wozniak AN, Beuschel S, Leavitt B, Bhave A, Butnor K, Koenig A, Chouchani ET, James AM, Haynes AC, Lowthere WT, Murphy MP, Shukla A, Heintz NH. Disabling mitochondrial peroxide metabolism via combinatorial targeting of peroxiredoxin 3 as an effective therapeutic approach for malignant mesothelioma. PLoS ONE 2015;10(5):e0127310

Sauter JL, Butnor KJ. Pathologic findings in spontaneous pneumothorax specimens: Does the incidence of unexpected clinically significant findings justify routine histologic examination? Histopathology 2015;66(5):675-684

Sauter JL, Butnor KJ. Expanding the spectrum of pulmonary histopathologic manifestations of anti-synthetase syndrome: Anti-EJ-associated acute fibrinous and organizing pneumonia. Histopathology 2014;65(4):581-585

Maxwell AWP, Klein JS, Dantey K, Mount SL, Butnor K, Leiman G.CT-guided transthoracic needle aspiration biopsy of subsolid lung lesions. J Vasc Interv Radiol 2014;25(3):340-346

For a complete list of Kelly Butnor's publications, please visit PubMed.